Home >Products> Reagents >Antibody> D-dimer Recombinant Rabbit mAb (SDT-117-26)
Reagents:  Molecular Biology   Biochemistry   Cell Biology   ELISA / Diagnostic Kits   Antibody   Serum/Medium   Other Reagents  
D-dimer Recombinant Rabbit mAb (SDT-117-26)
D-dimer Recombinant Rabbit mAb (SDT-117-26)
Place of Origin:
Singapore
Brand:
Starter
Model:
S0B3106-1mg
Price:
270
Hits:
Updated:
8/25/2025
  • Product Detail
  • Company Profile

    Product Specification


    HostRabbit
    AntigenD-dimer
    SynonymsN/A
    ImmunogenNative protein
    LocationN/A
    Clone NumberSDT-117-26
    Antibody TypeRecombinant mAb
    ApplicationCLIA, Sandwich ELISA
    ReactivityHu
    Cross ReactivityDoes not recognize fibrinogen
    PurificationProtein A
    Concentration2 mg/ml
    Purity>95% by HPLC
    ConjugationUnconjugated
    Physical AppearanceLiquid
    Storage BufferPBS pH7.4, 0.03% Proclin 300
    Stability & Storage

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied.

    Dilution


    applicationdilutionspecies
    CLIA N/A
    N/A

    Background

    D-dimer (or D dimer) is a dimer that is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link, hence forming a protein dimer. D-dimer concentration may be determined by a blood test to help diagnose thrombosis. Since its introduction in the 1990s, it has become an important test performed in people with suspected thrombotic disorders, such as venous thromboembolism. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis but does not exclude other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low. D-dimer levels are used as a predictive biomarker for the blood disorder disseminated intravascular coagulation and in the coagulation disorders associated with COVID-19 infection. A four-fold increase in the protein is an indicator of poor prognosis in people hospitalized with COVID-19.

    bio-equip.cn
    AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.